Corporate Colonialism Unveiled
A deep dive into the financial implications of genetic sequences reveals a troubling trend of corporate colonialism, where pharmaceutical giants profit from indigenous knowledge without fair compensation. The discussion highlights a recent treaty aimed at ensuring nations receive royalties for their genetic information, emphasizing the ongoing struggle for equitable benefit sharing in the pharmaceutical industry.In this clip
From this podcast
Doc Malik
#209 - James Roguski On The IHR Amendments And WHO Treaty
Related Questions